(PDF) Adjuvant recMAGE-A3 Immunotherapy After Cystectomy

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-Invasive Bladder Cancer: Lessons Learned From the Phase 2 MAGNOLIA Clinical Trial

European Urology Focus - Netherlands

doi 10.1016/j.euf.2018.02.005

Full Text

Abstract

Available in full text

Categories

Date

September 1, 2019

Authors

Peter F.A. Mulders

Luis Martínez-Piñeiro

Axel Heidenreich

Piotr Radziszewski

Cristian Surcel

J. Alfred Witjes

Christien Caris

Raymond Schipper

Wim P.J. Witjes

Publisher

Elsevier BV

Related search

Survival After Cystectomy for Invasive Bladder Cancer

European Journal of Surgical Oncology

English

Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Cancer Research

English

Randomized Trial of Adjuvant Therapies After Radical Cystectomy for Locally Advanced Bladder Cancer: Squamous Cell Carcinoma Subgroup Analysis

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

IL-9 BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer in Europe

Japanese Journal of Urology

English

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer Research

English

Muscle Invasive Bladder Cancer Survival After Radical Cystectomy or Definitive Chemoradiation: A National Cancer Database Matched Pair Analysis

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Study Protocol of a Phase II Clinical Trial of Oral Metformin for the Intravesical Treatment of Non-Muscle Invasive Bladder Cancer

Cancer Research

English

Adjuvant Chemotherapy Versus Observation After Radical Cystectomy in Patients With Node-Positive Bladder Cancer

Scientific Reports

Multidisciplinary

English

Editorial Title: Lessons Learned From a “Failed” Clinical Trial

Arthritis and Rheumatology

English